These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19790239)

  • 1. Tranilast suppresses prostate cancer growth and osteoclast differentiation in vivo and in vitro.
    Sato S; Takahashi S; Asamoto M; Naiki T; Naiki-Ito A; Asai K; Shirai T
    Prostate; 2010 Feb; 70(3):229-38. PubMed ID: 19790239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer.
    Subramaniam V; Chakrabarti R; Prud'homme GJ; Jothy S
    Anticancer Drugs; 2010 Apr; 21(4):351-61. PubMed ID: 20145538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.
    Wang P; Zou XM; Huang J; Zhang TL; Wang K
    Cell Biol Int; 2011 Nov; 35(11):1159-67. PubMed ID: 21605080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway.
    Zhu H; Han B; Pan X; Qi H; Xu L
    J Clin Pharm Ther; 2012 Feb; 37(1):65-70. PubMed ID: 21410737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation.
    Araujo JC; Poblenz A; Corn P; Parikh NU; Starbuck MW; Thompson JT; Lee F; Logothetis CJ; Darnay BG
    Cancer Biol Ther; 2009 Nov; 8(22):2153-9. PubMed ID: 19855158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
    Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
    Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
    Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Koeffler HP; Taguchi H
    Oncol Rep; 2006 Jun; 15(6):1581-90. PubMed ID: 16685399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
    Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
    J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
    J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
    Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
    Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
    Yonou H; Kanomata N; Goya M; Kamijo T; Yokose T; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
    Cancer Res; 2003 May; 63(9):2096-102. PubMed ID: 12727825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment.
    Sato S; Futakuchi M; Ogawa K; Asamoto M; Nakao K; Asai K; Shirai T
    Cancer Sci; 2008 Feb; 99(2):316-23. PubMed ID: 18271931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular interactions in the tropism of prostate cancer to bone.
    Sikes RA; Nicholson BE; Koeneman KS; Edlund NM; Bissonette EA; Bradley MJ; Thalmann GN; Cecchini MG; Pienta KJ; Chung LW
    Int J Cancer; 2004 Jul; 110(4):497-503. PubMed ID: 15122581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
    Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
    J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.
    Shigemura K; Arbiser JL; Sun SY; Zayzafoon M; Johnstone PA; Fujisawa M; Gotoh A; Weksler B; Zhau HE; Chung LW
    Cancer; 2007 Apr; 109(7):1279-89. PubMed ID: 17326044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranilast enhances the effect of anticancer agents in osteosarcoma.
    Nakashima T; Nagano S; Setoguchi T; Sasaki H; Saitoh Y; Maeda S; Komiya S; Taniguchi N
    Oncol Rep; 2019 Jul; 42(1):176-188. PubMed ID: 31059083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.